Sphincter of Oddi Dysfunction: Pancreaticobiliary Sphincterotomy with Pancreatic Stent Placement Has a Lower Rate of Pancreatitis Than Biliary Sphincterotomy Alone

Background and Study Aims: Patients with suspected or documented sphincter of Oddi dysfunction (SOD) who undergo standard biliary sphincterotomy have high rates of post-procedure pancreatitis. Approximately 75 % of such patients have elevated basal pressures of the pancreatic sphincter. Biliary sphincterotomy (BES) on its own leaves the pancreatic sphincter unablated and may cause transient edema which aggravates the increase in pancreatic sphincter pressure. Combined pancreaticobiliary therapy (PBR), using pancreatic stenting in addition to sphincterotomy may therefore be safer.

Patients and Methods: The endoscopic retrograde cholangiopancreatography (ERCP) database was queried for patients with successful double-duct sphincter of Oddi manometry (SOM) who underwent BES alone or PBR between 1994 and 1997. The endoscopist had decided on the technique to be used. From 1995 to 1997 there was a general trend to do PBR. Pancreatitis was defined according to established criteria.

Results: The post-ERCP pancreatitis rate among all 436 SOD patients was 19.7 %, while 256 patients with normal SOM results had a pancreatitis rate of 12.9 %. The use of combined PBR was associated with a lower frequency of pancreatitis compared with BES alone (needle-knife over pancreatic duct stent, 14/131 patients, 10.7 %; pull-type pancreaticobiliary sphincterotomy plus pancreatic stent, 15/78 patients, 19.2 %; BES alone, 52/184 patients, 28.3 %). Episodes of moderate and severe pancreatitis were seen more frequently in the BES group.

Conclusion: In SOD patients, post-ERCP pancreatitis rates remain high, but have improved with the addition of combined pancreaticobiliary sphincter therapy.

References

• 1 Rolny P, Arleback A, Funch-Jensen P. et al . Clinical significance of manometric assessment of both pancreatic duct and bile duct sphincter in the same patient.  Scand J Gastroenterol. 1989;  24 751-754
• 2 Silverman W B, Ruffolo T A, Sherman S. et al . Correlation of basal sphincter pressures measured from both the bile duct and pancreatic duct in patients with suspected sphincter of Oddi dysfunction.  Gastrointest Endosc. 1992;  38 440-443
• 3 Raddawi H, Geenen J, Hogan W. et al . Pressure measurements from biliary and pancreatic segments of sphincter of Oddi - comparison between patients with abdominal pain, biliary, or pancreatic disease.  Dig Dis Sci. 1991;  36 71-74
• 4 Eversman D, Fogel E L, Rusche M. et al . Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction.  Gastrointest Endosc. 1999;  50 637-641
• 5 Lehman G, Sherman S. Sphincter of Oddi dysfunction.  Int J Pancreatol. 1996;  20 11-25
• 6 Guelrud M, Plaz J, Mendoza S. et al . Endoscopic treatment in type II pancreatic sphincter dysfunction [abstract].  Gastrointest Endosc. 1995;  41 398
• 7 Soffer E E, Johlin F C. Intestinal dysmotility in patients with sphincter of Oddi dysfunction: a reason for failed response to sphincterotomy.  Dig Dis Sci. 1994;  39 1942-1946
• 8 Esber E, Sherman S, Earle D. et al . Complications of endoscopic pancreatic sphincterotomy: a review of 236 patients [abstract].  Gastrointest Endosc. 1996;  43 405
• 9 Choudari C P, Fogel E, Gottlieb K. et al . Therapeutic biliary endoscopy.  Endoscopy. 1998;  30 163-173
• 10 Hogan W J, Geenen J E. Biliary dyskinesia.  Endoscopy. 1988;  20 Suppl 1 179-183
• 11 Sherman S, Lehman G, Jamidar P. et al . Efficacy of endoscopic sphincterotomy and surgical sphincteroplasty for patients with sphincter of Oddi dysfunction (SOD): randomized, controlled study [abstract].  Gastrointest Endosc. 1994;  40 125
• 12 Sherman S, Troiano F P, Hawes R H. et al . Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction.  Am J Gastroenterol. 1991;  86 586-590
• 13 Guelrud M, Mendoza S, Rossiter G, Villegas M I. Sphincter of Oddi manometry in healthy volunteers.  Dig Dis Sci. 1990;  35 38-46
• 14 Sherman S, Gottlieb K, Uzer M F. et al . Effects of meperidine on the pancreatic and biliary sphincter.  Gastrointest Endosc. 1996;  44 239-242
• 15 Fogel E, Sherman S, Bucksot L, Lehman G. Effects of droperidol on the biliary and pancreatic sphincter [abstract].  Gastrointest Endosc. 1999;  49 78
• 16 Cotton P B, Lehman G, Vennes J A. et al . Endoscopic sphincterotomy complications and their management: an attempt at consensus.  Gastrointest Endosc. 1991;  37 383-393
• 17 Sherman S, Troiano F P, Hawes R H, Lehman G A. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with the use of a modified aspirating catheter.  Gastrointest Endosc. 1990;  36 462-466
• 18 Freeman M L, Nelson D B, Sherman S. et al . Complications of endoscopic biliary sphincterotomy.  N Engl J Med. 1996;  335 909-918
• 19 Tarnasky P R, Palesch Y, Cunningham J T. et al . Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction: a prospective randomized trial [abstract].  Gastrointest Endosc. 1997;  45 150
• 20 Sherman S, Eversman D, Fogel E. et al . Sphincter of Oddi dysfunction (SOD): needle-knife pancreato-biliary sphincterotomy over pancreatic stent (NKOPS) has a lower post-procedure pancreatitis rate than pull-type biliary sphincterotomy (BES) [abstract].  Gastrointest Endosc. 1997;  45 148
• 21 Smithline A, Silverman W, Rogers D. et al . Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients.  Gastrointest Endosc. 1993;  39 652-657
• 22 Meyerson S M, Geenen J E, Johnson G K. et al . Pancreatic duct stenting decreases the incidence of post-ERCP pancreatitis: a prospective randomized study [abstract].  Gastroenterology. 1998;  114 G1967
• 23 Elton E, Howell D A, Parsons W G. et al . Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique.  Gastrointest Endosc. 1998;  47 240-249
• 24 Sherman S, Ruffolo T A, Hawes R H, Lehman G A. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.  Gastroenterology. 1991;  101 1068-1075
• 25 Chen Y K, Foliente R L, Santoro M J. et al . Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction.  Am J Gastroenterol. 1994;  89 327-333
• 26 Sherman S. ERCP and endoscopic sphincterotomy-induced pancreatitis.  Am J Gastroenterol. 1994;  89 303-305
• 27 Tarnasky P, Cunningham J, Cotton P. et al . Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.  Endoscopy. 1997;  29 252-257
• 28 Freeman M L, Nelson D B, DiSario J A. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study [abstract].  Gastrointest Endosc. 1999;  49 72
• 29 Lehman G A, Sherman S. Diagnosis and therapy of pancreas divisum.  Gastrointest Endosc Clin N Amer. 1998;  8 55-77